Phathom Pharmaceuticals share price logo

Phathom Pharmaceuticals

NASDAQ: PHAT

Small Cap

$5.79

-1.21

(-17.33%)

Live

as on

Phathom Pharmaceuticals Stock Performance

as on October 24, 2026 at 6:27 am IST

  • Day's Low

    Day's High

    $5.01
    $6.76
    downward going graph

    13.47%

    Downside

    16.75%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.52
    $18.31
    downward going graph

    -12.61%

    Downside

    216.23%

    Upside

    downward going graph

Phathom Pharmaceuticals share price movements today

Previous Close
$7.01
Open
$6.70
Volume
3.9M
Market Cap
$568.7M
Day's Low - High
$5.01 - $6.76
52 Week Low - High
$6.52 - $18.31

Phathom Pharmaceuticals Historical Returns

1 Month Return
+ 0.36 %
3 Month Return
-39.57 %
1 Year Return
-48.49 %
3 Year Return
-25.19 %
5 Year Return
-75.99 %

Phathom Pharmaceuticals Stock Fundamentals & Key Indicators

Check Phathom Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$568.7M

EPS (TTM)

-1.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.49

Industry PE ratio

-7.12

PEG Ratio

-0.03

EBITDA

-35.1M

Revenue (TTM)

239.7M

Profit Margin

82.92%

Return On Equity TTM

25.70%

Phathom Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Phathom Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$568.7M-75.99%-5.4982.92%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Phathom Pharmaceuticals Stock including INR - Dollar returns

The Phathom Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Phathom Pharmaceuticals investment value today

Current value as on today

₹46,013

Returns

-₹53,987

(-53.99%)

Returns from Phathom Pharmaceuticals Stock

-₹57,458 (-57.46%)

Dollar Impact

₹3,471 (+3.47%)

Analyst Recommendation on Phathom Pharmaceuticals Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Phathom Pharmaceuticals. Average target price of $19.64

Phathom Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Phathom Pharmaceuticals.

What analysts predicted

70.52%UPSIDE

Target Price

$19.64

Current Price

$5.79

Analyzed by

5 Analysts

High

$26

Target

$19.64

Low

$15

Phathom Pharmaceuticals target price $19.64, a slight upside of 70.52% compared to current price of $5.79. According to 5 analysts rating.

Indian Investors' Interest in Phathom Pharmaceuticals Stock

Search interest for Phathom Pharmaceuticals Stock has increased by 224% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:224% versus previous 30 day period

Phathom Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
7
16
29
28
39
49
57
58
74
Gross Profit
1
5
13
25
24
34
43
49
46
59
Operating Income
-69
-77
-70
-59
-78
-59
-15
-5
-15
-3
EBITDA
-65
-73
-66
-55
-76
-58
-13
-4
-14
-2
Interest Expense
17
17
18
18
18
17
16
16
15
15
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-82
-91
-85
-74
-94
-75
-29
-21
-30
-17
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-82
-91
-85
-74
-94
-75
-29
-21
-30
-17
Net Profit Margin
77.72%
81.21%
85.59%
87.14%
86.94%
87.25%
87.50%
86.72%
79.42%
79.68%

Phathom Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
55
175
Gross Profit
-
0
0
0
0
0
47
152
Operating Income
-1
-106
-125
-135
-172
-167
-277
-159
EBITDA
0
-250
-124
-136
-169
-159
-261
-152
Interest Expense
0
4
4
6
27
41
72
68
Depreciation
1
0
0
0
0
0
0
0
Income Before Tax
-1
-255
-129
-143
-197
-201
-334
-221
Income Tax Expense
0
-
-
-
-
-
-
-
Net Income
-1
-209
-129
-143
-197
-201
-334
-221
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
75.51%
85.57%
87.09%

Phathom Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-82
-91
-85
-74
-94
-75
-29
-21
-30
-17
Operating Cash Flow
-69
-70
-63
-63
-84
-62
-14
-5
-15
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
9
24
122
26
-
0
0
0
66
3
Change in Cash
-59
-45
58
-37
-84
-62
-14
-5
50
1

Phathom Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-255
-129
-143
-197
-201
-334
-221
Operating Cash Flow
-1
-36
-69
-148
-146
-137
-266
-166
Investing Cash Flow
-
-25
-1
0
-1
-1
0
0
Financing Cash Flow
1
304
114
44
120
367
182
0
Change in Cash
0
242
43
-104
-27
228
-84
-167

Global Institutional Holdings in Phathom Pharmaceuticals

Check out the Institutions with significant holdings in Phathom Pharmaceuticals.

Funds
Holdings
Vanguard
3.91%
iShares
3.42%
VANGUARD INDEX FUNDS
3.12%
WASATCH FUNDS TRUST
1.61%
Franklin Strategic Series
1.30%

Phathom Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 23 October

    Fri, 02:40 PM

    -

    BDR Pharmaceuticals files suit against FDA, challenging exclusivity for Phathom's Voquezna drug application.

Insights on Phathom Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 720.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 182.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PHAT stock has moved down by -39.6%

About Phathom Pharmaceuticals

Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company is vonoprazan, a distinctive potassium-competitive acid blocker (P-CAB) designed to effectively inhibit gastric acid production, for which Phathom holds commercial rights across the United States, Europe, and Canada. This compound is currently undergoing advanced (Phase III) clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD), and also as a component of combination therapy with antibiotics to combat Helicobacter pylori (H. pylori) infection. Established in 2018, Phathom Pharmaceuticals maintains its corporate headquarters in Florham Park, New Jersey.
OrganisationPhathom Pharmaceuticals
Headquarters100 Campus Drive, Florham Park, NJ, 07932, US
IndustryBiotechnology
CEOSteven L. Basta

Key Management of Phathom Pharmaceuticals

Name

Title

Mr. David A. Socks

Co-Founder

Mr. Sanjeev Narula

Chief Financial & Business Officer

Mr. Robert Breedlove

VP of Finance & Principal Accounting Officer

Mr. Eric Sciorilli

Director of Business Development & Investor Relations

Mr. Bill Aprea J.D.

Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer

Mr. Steven L. Basta M.B.A.

CEO, President & Director

Dr. Azmi Nabulsi M.D., M.P.H.

Co-Founder

Ms. Anne Marie Cook Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Jonathan Bentley

Senior VP and Head of Sales, Operations & Training

Ms. Nancy R. Phelan

Senior Vice President of Marketing & Analytics

FAQs

What is Phathom Pharmaceuticals share price today?

Phathom Pharmaceuticals share price today is $5.79 as on . Phathom Pharmaceuticals share today touched a day high of $6.76 and a low of $5.01.

What is the 52 week high and 52 week low for Phathom Pharmaceuticals share?

Phathom Pharmaceuticals share touched a 52 week high of $18.31 on and a 52 week low of $6.52 on . Phathom Pharmaceuticals stock price today i.e. is trending at $5.79,which is 68.38% down from its 52 week high and -11.20% up from its 52 week low.

What is Phathom Pharmaceuticals's market capitalisation today?

Phathom Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Phathom Pharmaceuticals Stock (PHAT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Phathom Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Phathom Pharmaceuticals Stock (PHAT) from India?

Indian investors can start investing in Phathom Pharmaceuticals (PHAT) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Phathom Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Phathom Pharmaceuticals share’s latest price of $5.79 as on October 24, 2026 at 12:57 am IST, you will get 1.7271 shares of Phathom Pharmaceuticals. Learn more about fractional shares .

What are the returns that Phathom Pharmaceuticals has given to Indian investors in the last 5 years?

Phathom Pharmaceuticals stock has given -75.99% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?